Vytrus Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Vytrus Biotech has a total shareholder equity of €5.3M and total debt of €2.1M, which brings its debt-to-equity ratio to 39.3%. Its total assets and total liabilities are €9.3M and €4.0M respectively. Vytrus Biotech's EBIT is €404.4K making its interest coverage ratio 2.9. It has cash and short-term investments of €1.1M.
Key information
39.3%
Debt to equity ratio
€2.08m
Debt
| Interest coverage ratio | 2.9x |
| Cash | €1.11m |
| Equity | €5.29m |
| Total liabilities | €4.02m |
| Total assets | €9.31m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: V5P's short term assets (€2.5M) exceed its short term liabilities (€995.8K).
Long Term Liabilities: V5P's short term assets (€2.5M) do not cover its long term liabilities (€3.0M).
Debt to Equity History and Analysis
Debt Level: V5P's net debt to equity ratio (18.4%) is considered satisfactory.
Reducing Debt: V5P's debt to equity ratio has reduced from 59.4% to 39.3% over the past 5 years.
Debt Coverage: V5P's debt is well covered by operating cash flow (43.5%).
Interest Coverage: V5P's interest payments on its debt are not well covered by EBIT (2.9x coverage).